MedRx Co., Ltd

4586.T
Drug Manufacturers - Specialty & Generic
2026/11/12 20:08 Updated
Market Cap: $15.8M (¥2.5B)
Stock Price: $0.24 (¥38)
Exchange Rate: 1 USD = ¥159.49

Notice Regarding Large-Scale Exercise of the 35th Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause)

A large-scale exercise of the 35th stock acquisition rights allotted to Growth Capital Co., Ltd. has occurred. The number of shares delivered since the beginning of the month is 1,496,500 shares, and the number of exercised stock acquisition rights is 14,965 units (10.12% of total issued). Outstanding unexercised rights have decreased to 13,431 units (1,343,100 shares). The applicable period is November 1, 2026 to November 12, 2026.

Importance:
Page Updated: November 12, 2026
IR Disclosure Date: November 12, 2026

Key Figures

  • Delivered shares: 1,496,500 shares
  • Number of stock acquisition rights exercised: 14,965 units
  • Exercise ratio to total issued: 10.12%
  • Number of unexercised stock acquisition rights: 13,431 units (1,343,100 shares)

AI要約

Overview

These stock acquisition rights were issued by third-party allotment, and the applicable period is November 1, 2026 to November 12, 2026. The number of shares delivered at the beginning of the month was 1,496,500 shares. Since the beginning of the month, 14,965 rights have been exercised (10.12% of total issued), and outstanding unexercised rights have decreased to 13,431 units (1,343,100 shares).

Outlook and Impact

The exercise status from November 2 to 12 was disclosed, and shares have been transferred as treasury stock. The ratio to total issued has been rounded to three decimal places where applicable, and the exercise trend during the period has progressed quantitatively. Future movements of unexercised rights may affect share dilution and shareholder composition.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

MedRx Co., Ltd

Company overview · Stock price · Financial data · All IR

View company page →